|1.||Nord, O: 1 article (11/2009)|
|2.||Löfdahl, P-A: 1 article (11/2009)|
|3.||Nygren, P-A: 1 article (11/2009)|
|4.||Janzon, L: 1 article (11/2009)|
|5.||Iwata, Satoshi: 1 article (06/2006)|
|6.||Morozumi, Miyuki: 1 article (06/2006)|
|7.||Takada, Emi: 1 article (06/2006)|
|8.||Ubukata, Kimiko: 1 article (06/2006)|
|9.||Sunakawa, Keisuke: 1 article (06/2006)|
|10.||Chiba, Naoko: 1 article (06/2006)|
11/30/2009 - "The present study describes the construction of a PCA system based on genetic splitting of TEM-1 beta-lactamase for the selection of proteins specifically interacting in the periplasm of Escherichia coli bacterial cells, and its application for the selection of affibody molecules binding human tumour necrosis factor-alpha (TNF-alpha) from a combinatorial library. "
03/01/2005 - " cirrhosis patients who suffered from Aeromonas infection had poor prognosis and had mortality rate of 3/4. The beta-lactamase TEM-1 resistant genes was detected in clinical multiresistant Aeromonas strain isolated from serious cirrhosis patients.The"
11/07/1981 - "Documented ampicillin treatment failures of systemic Haemophilus influenzae type b infections have been associated with synthesis of a TEM-1 beta-lactamase. "
02/01/1990 - "During an outbreak of infection with ampicillin-resistant, TEM-1 beta-lactamase-producing Escherichia coli serotype O15, some strains were noted to differ from the majority in that they showed reduced susceptibility to amoxycillin/clavulanic acid (Augmentin), ureidopenicillins and first generation cephalosporins and produced increased amounts of beta-lactamase. "
|2.||Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||Proteins (Proteins, Gene)
|6.||Cephalosporins (Cephalosporin Antibiotics)